ArticlePediatric blood & cancer2015

Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program.

E Anders Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.